Abstract
Our own studies and those of others have shown that defects in essential fatty acid (EFA) metabolism occurs in age-related disorders such as obesity, type 2 diabetes mellitus, hypertension, atherosclerosis, coronary heart disease, immune dysfunction and cancer. It has been noted that in all these disorders there could occur a defect in the activities of desaturases, cyclo-oxygenase (COX), and lipoxygenase (LOX) enzymes leading to a decrease in the formation of their long-chain products gamma-linolenic acid (GLA), arachidonic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). This leads to an increase in the production of pro-inflammatory prostaglandin E2 (PGE2), thromboxanes (TXs), and leukotrienes (LTs) and a decrease in anti-inflammatory lipoxin A4, resolvins, protectins and maresins. All these bioactive molecules are termed as bioactive lipids (BALs). This imbalance in the metabolites of EFAs leads to low-grade systemic inflammation and at times acute inflammatory events at specific local sites that trigger the development of various age-related disorders such as obesity, type 2 diabetes mellitus, hypertension, coronary heart disease, atherosclerosis, and immune dysfunction as seen in rheumatoid arthritis, lupus, nephritis and other localized inflammatory conditions. This evidence implies that methods designed to restore BALs to normal can prevent age-related disorders and enhance longevity and health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Le Gall JY, Ardaillou R (2009) The biology of aging. Bull Acad Natl Med 193:365–402
Poorani R, Bhatt AN, Dwarakanath BS, Das UN (2016) COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. Eur J Pharmacol 785:116–132
Das UN (1985) Minerals, trace elements and vitamins interact with essential fatty acids and prostaglandins to prevent hypertension, thrombosis, hypercholesterolemia and atherosclerosis and their attendant complications. IRCS J Med Sci 13:684–687
Das UN (1987) Magnesium, essential fatty acids and cardiovascular diseases. J Assoc Physicians India 35:171
Das UN, Ramadevi G, Rao KP, Rao MS (1989) Prostaglandins can modify gamma-radiation and chemical induced cytotoxicity and genetic damage in vitro and in vivo. Prostaglandins 38:689–716
Das UN (1989) Nutrients, essential fatty acids and prostaglandins interact to augment immune responses and prevent genetic damage and cancer. Nutrition 5:106–110
Das UN (2000) Interaction(s) between nutrients, essential fatty acids, eicosanoids, free radicals, nitric oxide, anti-oxidants and endothelium and their relationship to human essential hypertension. Med Sci Res 28:75–83
Das UN (2006) Essential fatty acids: biochemistry, physiology, and pathology. Biotechnol J 1:420–439
Das UN (2006) Biological significance of essential fatty acids. J Assoc Physicians India 54:309–319
Das UN (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 7:37. https://doi.org/10.1186/1476-511X-7-37
Das UN (2011) Molecular basis of health and disease. Springer, New York. ISBN-10: 9400704941
Das UN (1991) Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases. Prostaglandins Leukot Essent Fatty Acids 44:201–210
Kumar GS, Das UN (1994) Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids 50:331–334
Rotondo D, Earl CR, Laing KJ, Kaimakamis D (1994) Inhibition of cytokine-stimulated thymic lymphocyte proliferation by fatty acids: the role of eicosanoids. Biochim Biophys Acta 1223:185–194
Santoli D, Zurier RB (1989) Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism. J Immunol 143:1303–1309
Miles EA, Allen E, Calder PC (2002) In vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures. Cytokine 20:215–223
Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y (1997) Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 400B:589–597
Czeslick EG, Simm A, Grond S, Silber RE, Sablotzki A (2003) Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost. Eur J Clin Investig 33:1013–1017
Chen X, Wu S, Chen C, **e B, Fang Z, Hu W et al (2017) Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury. J Neuroinflammation 14:143. https://doi.org/10.1186/s12974-017-0917-3
Chen X, Chen C, Fan S, Wu S, Yang F, Fang Z et al (2018) Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury. J Neuroinflammation 15:116. https://doi.org/10.1186/s12974-018-1151-3
Chang CS, Sun HL, Lii CK, Chen HW, Chen PY, Liu KL (2010) Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages. Inflammation 33:46–57
Dooper MM, van Riel B, Graus YM, M’Rabet L (2003) Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity. Immunology 110:348–357
Das UN (2010) Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J Inflammation Res 3:143–170
Menezes-de-Lima O Jr, Kassuya CA, Nascimento AF, Md H, Calixto JB (2006) Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. Prostaglandins Other Lipid Mediat 80:123–135
Benabdoun HA, Kulbay M, Rondon EP, Vallières F, Shi Q, Fernandes J et al (2019) In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis. Arthritis Res Ther 21:72
Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M et al (2008) An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 155:1214–1223
Wu L, Miao S, Zou LB, Wu P, Hao H, Tang K et al (2012) Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury. J Mol Neurosci 48:185–200
Lee TH, Lympany P, Crea AE, Spur BW (1991) Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. Biochem Biophys Res Commun 180:1416–1421
McMahon B, Mitchell D, Shattock R, Martin F, Brady HR, Godson C (2002) Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 16:1817–1819
Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A et al (2006) Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A 103:11276–11281
Serhan CN, Dalli J, Karamnov S, Choi A, Park CK, Xu ZZ et al (2012) Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J 26:1755–1765
Naveen KVG, Naidu VGM, Das UN (2017) Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo. Biofactors 43:251–271
Naveen KVG, Naidu VGM, Das UN (2017) Arachidonic acid and lipoxin A4 attenuate streptozotocin-induced cytotoxicity to RIN5F cells in vitro and type 1 and type 2 diabetes mellitus in vivo. Nutrition 35:61–80
Das UN, Ells G, Begin ME, Horrobin DF (1986) Free radicals as possible mediators of the actions of interferon. J Free Rad Biol Med 2:183–188
Das UN, Padma M, Sangeetha P, Ramesh G, Koratkar R (1990) Stimulation of free radical generation in human leukocytes by various stimulants including tumor necrosis factor is a calmodulin dependent process. Biochem Biophys Res Commun 167:1030–1036
Tsujimoto M, Yokota S, Vilcek J, Weissman G (1986) Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun 137:1094–1100
Beton G, Zeni L, Casaatella MA, Rossi F (1986) Gamma-interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 138:1276–1282
Das UN, Huang YS, Begin ME, Horrobin DF (1986) Interferons, phospholipid metabolism, immune responses and cancer. IRCS Med Sci 14:1069–1074
Bordoni A, Hrelia S, Lorenzini A, Bergami R, Cabrini L, Biagi PL et al (1998) Dual influence of aging and vitamin B6 deficiency on delta-6-desaturation of essential fatty acids in rat liver microsomes. Prostaglandins Leukot Essent Fatty Acids 58:417–420
Bordoni A, Biagi PL, Turchetto E, Hrelia S (1988) Aging influence on delta-6-desaturase activity and fatty acid composition of rat liver microsomes. Biochem Int 17:1001–1009
Biagi PL, Bordoni A, Hrelia S, Celadon M, Horrobin DF (1991) Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. Biochim Biophys Acta 1083:187–192
Lopez Jimenez JA, Bordoni A, Lorenzini A, Rossi CA, Biagi PL, Hrelia S (1997) Linoleic acid metabolism in primary cultures of adult rat cardiomyocytes is impaired by aging. Biochem Biophys Res Commun 237:142–145
Lorenzini A, Bordoni A, Spanò C, Turchetto E, Biagi PL, Hrelia S (1997) Age-related changes in essential fatty acid metabolism in cultured rat heart myocytes. Prostaglandins Leukot Essent Fatty Acids 57:143–147
Bourre JM, Piciotti M, Dumont O (1990) Delta 6 desaturase in brain and liver during development and aging. Lipids 25:354–356
Horrobin DF (1981) Loss of delta-6-desaturase activity as a key factor in aging. Med Hypotheses 7:1211–1220
Das UN (2007) A defect in the activity of Delta6 and Delta5 desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 76:251–268
Das UN (2018) Ageing: is there a role for arachidonic acid and other bioactive lipids? A review. J Adv Res 11:67–79
Shim JH (2019) Prostaglandin E2 induces skin aging via E-prostanoid 1 in normal human dermal fibroblasts. Int J Mol Sci 20(22). pii: E5555. https://doi.org/10.3390/ijms20225555
Young MK, Bocek RM, Herrington PT, Beatty CH (1981) Ageing: effects on the prostaglandin production by skeletal muscle of male rhesus monkeys (Macaca mulatta). Mech Ageing Dev 16:345–353
Fraifeld V, Kaplanski J, Kukulansky T, Globerson A (1995) Increased prostaglandin E2 production by concanavalin A-stimulated splenocytes of old mice. Gerontology 41:129–133
Hayek MG, Meydani SN, Meydani M, Blumberg JB (1994) Age differences in eicosanoid production of mouse splenocytes: effects on mitogen-induced T-cell proliferation. J Gerontol 49:B197–B207
Wu D, Mura C, Beharka AA, Han SN, Paulson KE, Hwang D et al (1998) Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Phys 275:C661–C668
Baek BS, Kim JW, Lee JH, Kwon HJ, Kim ND, Kang HS et al (2001) Age-related increase of brain cyclooxygenase activity and dietary modulation of oxidative status. J Gerontol A Biol Sci Med Sci 56:B426–B431
Gangemi S, Pescara L, D’Urbano E, Basile G, Nicita-Mauro V, Davì G et al (2005) Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol 40:612–614
Das UN (2020) Molecular pathobiology of scleritis and its therapeutic implications. Int J Ophthalmol 13(1):163–175
Das UN (2019) Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: a review. J Adv Res 17:17–29
Das UN (2019) Polyunsaturated fatty acids and sepsis. Nutrition 65:39–43
Das UN (2019) Bioactive lipids in intervertebral disc (IVD) degeneration and its therapeutic implications. BioSci Rep 39(10). pii: BSR20192117. https://doi.org/10.1042/BSR20192117
Das UN (2019) Bioactive lipids in shoulder tendon tears. Am J Pathol 189:2149–2153
Dakin SG, Colas RA, Wheway K, Watkins B, Appleton L, Rees J et al (2019) Proresolving mediators LXB4 and RvE1 regulate inflammation in stromal cells from patients with shoulder tendon tears. Am J Pathol 189:2258–2268
Das UN (2019) Can bioactive lipid(s) augment anti-cancer action of immunotherapy and prevent cytokine storm? Arch Med Res 50:342–349
Das UN (2020) Bioactive lipids as modulators of immune check point inhibitors. Med Hypotheses 135:109473. https://doi.org/10.1016/j.mehy.2019.109473
Das UN (2018) Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus. J Adv Res 11:43–55
Das UN (2010) Essential fatty acids and their metabolites in the context of hypertension. Hypertens Res 33:782–785
Inoue K, Kishida K, Hirata A, Funahashi T, Shimomura I (2013) Low serum eicosapentaenoic acid/arachidonic acid ratio in male subjects with visceral obesity. Nutr Metab (Lond) 10:25. https://doi.org/10.1186/1743-7075-10-25
Yagi S, Aihara K, Fukuda D, Takashima A, Bando M, Hara T et al (2015) Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome. Nutr J 14:111. https://doi.org/10.1186/s12937-015-0102-4
Yagi S, Hara T, Ueno R, Aihara K, Fukuda D, Takashima A et al (2014) Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutr J 13:112. https://doi.org/10.1186/1475-2891-13-112
Das UN (2013) Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids 88:201–210
Das UN (2007) Vagus nerve stimulation, depression and inflammation. Neuropsychopharmacology 32:2053–2054
Das UN (2017) Is there a role for bioactive lipids in the pathobiology of diabetes mellitus? Front Endocrinol (Lausanne) 8:182. https://doi.org/10.3389/fendo.2017.00182
Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF et al (2012) Lipoxin A4 attenuates adipose inflammation. FASEB J 26:4287–4294
Das UN (2011) Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis 10:76. https://doi.org/10.1186/1476-511X-10-76
Das UN (2016) Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome. J Transl Int Med 4:66–72
Kain V, Ingle KA, Colas RA, Dalli J, Prabhu SD, Serhan CN et al (2015) Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol 84:24–35
Mai J, Liu W, Fang Y, Zhang S, Qiu Q, Yang Y et al (2018) The atheroprotective role of lipoxin A4 prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway. Atherosclerosis 278:259–268
Kain V, Liu F, Kozlovskaya V, Ingle KA, Bolisetty S, Agarwal A et al (2017) Resolution agonist 15-epi-lipoxin A4 programs early activation of resolving phase in post-myocardial infarction healing. Sci Rep 7:9999. https://doi.org/10.1038/s41598-017-10441-8
Schnittert J, Heinrich MA, Kuninty PR, Storm G, Prakash J (2018) Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. Cancer Lett 420:247–258
Simões RL, De-Brito NM, Cunha-Costa H, Morandi V, Fierro IM, Roitt IM et al (2017) Lipoxin A4 selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression. Int J Cancer 140:346–357
Wang Z, Cheng Q, Tang K, Sun Y, Zhang K, Zhang Y et al (2015) Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells. Cancer Lett 364:118–124
Xu F, Zhou X, Hao J, Dai H, Zhang J, He Y et al (2018) Lipoxin A4 and its analog suppress hepatocarcinoma cell epithelial-mesenchymal transition, migration and metastasis via regulating integrin-linked kinase axis. Prostaglandins Other Lipid Mediat 137:9–19
Liu C, Guan H, Cai C, Li F, **ao J (2017) Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss. Exp Cell Res 352:293–303
Banu J, Bhattacharya A, Rahman M, Kang JX, Fernandes G (2010) Endogenously produced n-3 fatty acids protect against ovariectomy induced bone loss in fat-1 transgenic mice. J Bone Miner Metab 28:617–626
Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G (2003) Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206–1216
Wei J, Chen S, Guo W, Feng B, Yang S, Huang C, Chu J (2018) Leukotriene D4 induces cellular senescence in osteoblasts. Int Immunopharmacol 58:154–159
Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR et al (2005) Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J Am Coll Nutr 24:200–209
Bhavsar PK, Levy BD, Hew MJ, Pfeffer MA, Kazani S, Israel E et al (2010) Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma. Respir Res 11:71. https://doi.org/10.1186/1465-9921-11-71
Tateishi N, Kakutani S, Kawashima H, Shibata H, Morita I (2014) Dietary supplementation of arachidonic acid increases arachidonic acid and lipoxin A4 contents in colon but does not affect severity or prostaglandin E2 content in murine colitis model. Lipids Health Dis 13:30. https://doi.org/10.1186/1476-511X-13-30
Tateishi N, Kaneda Y, Kakutani S, Kawashima H, Shibata H, Morita I (2015) Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis model. Lipids Health Dis 14:3. https://doi.org/10.1186/1476-511X-14-3
Das UN (2019) Circulating microparticles in septic shock and sepsis-related complications. Minerva Anestesiol. (in press)
Dakin SG, Ly L, Colas RA, Oppermann U, Wheway K, Watkins B et al (2017) Increased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy. Sci Rep 7:11009. https://doi.org/10.1038/s41598-017-11188-y
Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP et al (2015) Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348:aaa2340. https://doi.org/10.1126/science.aaa2340
FitzGerald GA (2015) Bringing PGE2 in from the cold. Science 348:1208–1209
Duffin R, O’Connor RA, Crittenden S, Forster T, Yu C, Zheng X et al (2016) Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell–IL-22 axis. Science 351:1333–1338
Ueda T, Fukunaga K, Seki H, Miyata J, Arita M, Miyasho T et al (2014) Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis. Crit Care Med 42:e288–e295
Walker J, Dichter E, Lacorte G, Kerner D, Spur B, Rodriguez A et al (2011) Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 36:410–416
Wu B, Walker J, Spur B, Rodriguez A, Yin K (2015) Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis. Prostaglandins Leukot Essent Fatty Acids 94:55–64
Wu B, Capilato J, Pham MP, Walker J, Spur B, Rodriguez A et al (2016) Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition. FASEB J 30:2400–2410
Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA et al (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461:1287–1291
Desbois AP, Lawlor KC (2013) Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Mar Drugs 11:4544–4557
Das UN (2018) Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: a review. J Adv Res 11:57–66
Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG (2005) Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett 579:5157–5162
Le PNT, Desbois AP (2017) Antibacterial effect of eicosapentaenoic acid against Bacillus cereus and Staphylococcus aureus: killing kinetics, selection for resistance, and potential cellular target. Mar Drugs 15: pii: E334. https://doi.org/10.3390/md15110334
Giamarellos-Bourboulis EJ, Grecka P, Dionyssiou-Asteriou A, Giamarellou H (1998) In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58:283–287
Das UN (1985) Antibiotic-like action of essential fatty acids. Can Med Assoc J 132:1350
Lee KA, Shin KS, Kim GY, Song YC, Bae EA, Kim IK et al (2016) Characterization of age-associated exhausted CD8+ T cells defined by increased expression of Tim-3 and PD-1. Aging Cell 15:291–300
Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C (2010) Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway. Aging Cell 9:785–798
Shimada Y, Hayashi M, Nagasaka Y, Ohno-Iwashita Y, Inomata M (2009) Age-associated up-regulation of a negative co-stimulatory receptor PD-1 in mouse CD4+ T cells. Exp Gerontol 44:517–522
Fukushima Y, Minato N, Hattori M (2018) The impact of senescence-associated T cells on immunosenescence and age-related disorders. Inflamm Regen 38:24. https://doi.org/10.1186/s41232-018-0082-9
Harris SG, Padilla J, Koumas L, Ray D, Phipps RP (2002) Prostaglandins as modulators of immunity. Trends Immunol 23:144–150
Kalinski P (2012) Regulation of immune responses by prostaglandin e2. J Immunol 188:21–28
Das UN, Padma MC (1978) Prostaglandins in lymphocyte transformation. J Assoc Physicians India 26:503–506
Das UN (1980) Prostaglandins and immune response in cancer. Int J Tiss Reac 2:233–236
Das UN (1981) Inhibition of sensitized lymphocyte response to sperm antigen(s) by prostaglandins. IRCS Med Sci 9:1087
Kumar GS, Das UN, Kumar KV, Madhavi DNP, Tan BKH (1992) Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutr Res 12:815–823
Das UN (2014) HLA-DR expression, cytokines and bioactive lipids in sepsis. Arch Med Sci 10:325–335
Narumiya S (2007) Physiology and pathophysiology of prostanoid receptors. Proc Jpn Acad Ser B 83:296–319
Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295–315
Betz M, Fox BS (1991) Prostaglandin E2 inhibits production of TH1 lymphokines but not of Th2 lymphokines. J Immunol 146:108–113
Gold KN, Weyand CM, Goronzy JJ (1994) Modulation of helper T cell function by prostaglandins. Arthritis Rheum 37:925–933
Hilkens CM, Vermeulen H, van Neerven RJ, Snijdewint FG, Wierenga EA, Kapsenberg ML (1995) Differential modulation of T helper type 1 (TH1) and T helper type 2 (TH2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 25:59–63
Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K et al (2009) Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Nat Med 15:633–640
Linnemeyer PA, Pollack SB (1993) Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. J Immunol 150:3747–3754
Sreeramkumar V, Fresno M, Cuesta N (2012) Prostaglandin E2 and T cells: friends or foes? Immunol Cell Biol 90:579–586
Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 180:2365–2370
Demeure CE, Yang LP, Desjardins C, Raynauld P, Delespesse G (1997) Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur J Immunol 27:3526–3531
Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162–174
Owen K, Gomolka D, Droller MJ (1980) Production of prostaglandin E2 by tumor cells in vitro. Cancer Res 40:3167–3171
Young MR, Knies S (1984) Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo. J Natl Cancer Inst 72:919–922
Balch CM, Dougherty PA, Cloud GA, Tilden AB (1984) Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery 95:71–77
Murray JL, Kollmorgen GM (1983) Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma. J Clin Immunol 3:268–276
Passwell J, Levanon M, Davidsohn J, Ramot B (1983) Monocyte PGE2 secretion in Hodgkin’s disease and its relation to decreased cellular immunity. Clin Exp Immunol 51:61–68
Chiabrando C, Broggini M, Castagnoli MN, Donelli MG, Noseda A, Visintainer M et al (1985) Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth. Cancer Res 45:3605–3608
McLemore TL, Hubbard WC, Litterst CL, Liu MC, Miller S, McMahon NA et al (1988) Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res 48:3140–3247
Fulton AM (1988) Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells. Prostaglandins 35:413–425
Maxwell WJ, Kelleher D, Keating JJ, Hogan FP, Bloomfield FJ, MacDonald GS et al (1990) Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinoma. Digestion 47:160–166
Baxevanis CN, Reclos GJ, Gritzapis AD, Dedousis GV, Missitzis I, Papamichail M (1993) Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72:491–501
Alleva DG, Burger CJ, Elgert KD (1994) Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. J Immunol 153:1674–1686
Liu XH, Connolly JM, Rose DP (1996) Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin Exp Metastasis 14:145–152
Li S, Xu X, Jiang M, Bi Y, Xu J, Han M (2015) Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway. Mol Med Rep 11:4454–4462
Kim MJ, Kim HS, Lee SH, Yang Y, Lee MS, Lim JS (2014) NDRG2 controls COX-2/PGE2-mediated breast cancer cell migration and invasion. Mol Cells 37:759–765
Zhang M, Zhang H, Cheng S, Zhang D, Xu Y, Bai X et al (2006) Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells. Tumour Biol 35:7135–7145
Han C, Michalopoulos GK, Wu T (2006) Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 207:261–270
Han C, Wu T (2005) Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 280:24053–24063
Xu L, Han C, Wu T (2006) A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth. J Biol Chem 281:33982–33996
Misra UK, Pizzo SV (2013) Evidence for a pro-proliferative feedback loop in prostate cancer: the role of Epac1 and COX-2-dependent pathways. PLoS One 8:e63150. https://doi.org/10.1371/journal.pone
Evans DB, Thavarajah M, Kanis JA (1990) Involvement of prostaglandin E2 in the inhibition of osteocalcin synthesis by human osteoblast-like cells in response to cytokines and systemic hormones. Biochem Biophys Res Commun 167:194–202
Hori T, Yamanaka Y, Hayakawa M, Shibamoto S, Tsujimoto M, Oku N et al (1991) Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. Biochem Biophys Res Commun 174:758–766
Kambayashi T, Alexander HR, Fong M, Strassmann G (1995) Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol 154:3383–3390
Takigawa M, Takashiba S, Takahashi K, Arai H, Kurihara H, Murayama Y (1994) Prostaglandin E2 inhibits interleukin-6 release but not its transcription in human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor-alpha. J Periodontol 65:1122–1127
Fieren MW, van den Bemd GJ, Ben-Efraim S, Bonta IL (1992) Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Immunol Lett 31:85–90
Vassiliou E, **g H, Ganea D (2003) Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 223:120–132
Stafford JB, Marnett LJ (2008) Prostaglandin E2 inhibits tumor necrosis factor-alpha RNA through PKA type I. Biochem Biophys Res Commun 366:104–109
Xu XJ, Reichner JS, Mastrofrancesco B, Henry WL Jr, Albina JE (2008) Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production. J Immunol 180:2125–2131
Huang CN, Liu KL, Cheng CH, Lin YS, Lin MJ, Lin TH (2005) PGE2 enhances cytokine-elicited nitric oxide production in mouse cortical collecting duct cells. Nitric Oxide 12:150–158
Gaillard T, Mülsch A, Klein H, Decker K (1992) Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe Seyler 373:897–902
Stadler J, Harbrecht BG, Di Silvio M, Curran RD, Jordan ML, Simmons RL et al (1993) Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 53:165–172
Tetsuka T, Daphna-Iken D, Miller BW, Guan Z, Baier LD, Morrison AR (1996) Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J Clin Invest 97:2051–2056
Wilson KT, Vaandrager AB, De Vente J, Musch MW, De Jonge HR, Chang EB (1996) Production and localization of cGMP and PGE2 in nitroprusside-stimulated rat colonic ion transport. Am J Phys 270(3 Pt 1):C832–C840
Sautebin L, Ialenti A, Ianaro A, Di Rosa M (1995) Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur J Pharmacol 286:219–222
Biondi C, Fiorini S, Pavan B, Ferretti ME, Barion P, Vesce F (2003) Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells. J Reprod Immunol 60:35–52
Du Y, Sarthy VP, Kern TS (2004) Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol 287:R735–R741
Chien CC, Shen SC, Yang LY, Chen YC (2012) Prostaglandins as negative regulators against lipopolysaccharide, lipoteichoic acid, and peptidoglycan-induced inducible nitric oxide synthase/nitric oxide production through reactive oxygen species-dependent heme oxygenase 1 expression in macrophages. Shock 38:549–558
Stæhr M, Hansen PB, Madsen K, Vanhoutte PM, Nüsing RM, Jensen BL (2013) Deletion of cyclooxygenase-2 in the mouse increases arterial blood pressure with no impairment in renal NO production in response to chronic high salt intake. Am J Physiol Regul Integr Comp Physiol 304:R899–R907
Harizi H, Norbert G (2004) Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells. Cell Immunol 228:99–109
Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N (2002) Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168:2255–2263
Kanda N, Koike S, Watanabe S (2005) IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J Allergy Clin Immunol 116:1144–1150
Khayrullina T, Yen JH, **g H, Ganea D (2008) In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 181:721–735
Chen H, Qin J, Wei P, Zhang J, Li Q, Fu L et al (2009) Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells. Prostaglandins Leukot Essent Fatty Acids 80:195–200
Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90:7240–7244
Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR (1995) Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 114:1335–1342
Mollace V, Colasanti M, Muscoli C, Lauro GM, Iannone M, Rotiroti D et al (1998) The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells. Br J Pharmacol 124:742–746
Marcinkiewicz J (1997) Regulation of cytokine production by eicosanoids and nitric oxide. Arch Immunol Ther Exp 45:163–167
Tanaka M, Ishibashi H, Hirata Y, Miki K, Kudo J, Niho Y (1996) Tumor necrosis factor production by rat Kupffer cells-regulation by lipopolysaccharide, macrophage activating factor and prostaglandin E2. J Clin Lab Immunol 48:17–31
Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C et al (2002) Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun 290:249–255
Reznikov LL, Kim SH, Westcott JY, Frishman J, Fantuzzi G, Novick D et al (2000) IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. Proc Natl Acad Sci U S A 97:2174–2179
Perkins DJ, Kniss DA (1999) Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J Leukoc Biol 65:792–799
Sakurai T, Tamura K, Kogo H (2004) Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membrane-associated prostaglandin E synthase in rat luteal cells. J Endocrinol 183:527–533
Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P et al (2003) Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 63:586–592
Sailaja P, Mani AM, Naveen KVG, Anasuya DH, Siresha B, Das UN (2014) Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro. PLoS One 9:e114766. https://doi.org/10.1371/journal.pone.0114766
Booyens J, Englebrecht P, Le Roux S, Louwrens CC, Van der Merwe CF, Katzeff IE (1984) Some effects of the essential fatty acids linoleic acid, alpha-linolenic acid, and of their metabolites gamma-linolenic acid, arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid and of prostaglandins A and E on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukot Med 15:15–33
Begin ME, Das UN, Ells G, Horrobin DF (1985) Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med 19:177–186
Begin ME, Ells G, Das UN, Horrobin DF (1986) Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77:1053–1062
Das UN (1991) Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett 56:235–243
Sagar PS, Das UN, Koratkar R, Ramesh G, Padma M, Kumar GS (1992) Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells: relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett 63:189–198
Kumar GS, Das UN (1995) Free radical-dependent suppression of growth of mouse myeloma cells by α-linolenic and eicosapentaenoic acids in vitro. Cancer Lett 92:27–38
Padma M, Das UN (1996) Effect of cis-unsaturated fatty acids on cellular oxidant stress in macrophage tumor (AK-5) cells in vitro. Cancer Lett 109:63–75
Seigel I, Liu TL, Yaghoubzadeh E, Kaskey TS, Gleicher N (1987) Cytotoxic effects of free fatty acids on ascites tumor cells. J Natl Cancer Inst 78:271–277
Tolnai S, Morgan JF (1962) Studies on the in vitro anti-tumor activity of fatty acids. V. Unsaturated fatty acids. Can J Biochem Physiol 40:869–875
Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH (2006) Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis 27:1950–1960
Monjazeb AM, High KP, Koumenis C, Chilton FH (2005) Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins Leukot Essent Fatty Acids 73:463–474
Canuto RA, Muzio G, Bassi AM, Maggiora M, Leonarduzzi G, Lindahl R et al (1995) Enrichment with arachidonic acid increases the sensitivity of hepatoma cells to the cytotoxic effects of oxidative stress. Free Radic Biol Med 18:287–293
Piazzi G, D’Argenio G, Prossomariti A, Lembo V, Mazzone G, Candela M et al (2014) Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer 135:2004–2013
Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, Dauchy EM (2005) Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr 135:2124–2129
Gu Z, Wu J, Wang S, Suburu J, Chen H, Thomas MJ et al (2013) Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells. Carcinogenesis 34:1968–1975
Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS et al (2012) Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis 33:404–412
Blanckaert V, Ulmann L, Mimouni V, Antol J, Brancquart L, Chénais B (2010) Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int J Oncol 36:737–742
Collett ED, Davidson LA, Fan YY, Lupton JR, Chapkin RS (2001) n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 280:C1066–C1075
Havemose-Poulsen A, Sørensen LK, Stoltze K, Bendtzen K, Holmstrup P (2005) Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 76:2276–2285
Guimarães PM, Scavuzzi BM, Stadtlober NP, Franchi Santos LFDR, Lozovoy MAB, Iriyoda TMV et al (2017) Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles. Immunol Cell Biol 95:824–831
Yoshida T, Ichikawa Y, Tojo T, Homma M (1996) Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. Lupus 5:129–138
Navarro E, Esteve M, Olivé A, Klaassen J, Cabré E, Tena X et al (2000) Abnormal fatty acid pattern in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids. J Rheumatol 27:298–303
Suryaprabha P, Das UN, Ramesh G, Kumar KV, Kumar GS (1991) Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 43:251–255
Mohan IK, Das UN (1997) Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 56:193–198
Horrobin DF (1987) Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med Hypotheses 22:421–428
Horrobin DF (1984) Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren’s syndrome. Med Hypotheses 14:233–247
Laitinen O, Seppalä E, Nissilä M, Vapaatalo H (1983) Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis. Clin Rheumatol 2:401–406
Trang LE, Granström E, Lövgren O (1977) Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 6:151–154
Egg D (1984) Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. Z Rheumatol 43:89–96
Egg D, Günther R, Herold M, Kerschbaumer F (1980) Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases. Z Rheumatol 39:170–175
Das UN (2012) Is multiple sclerosis a proresolution deficiency disorder? Nutrition 28:951–958
Conte FP, Menezes-de-Lima O Jr, Verri WA Jr, Cunha FQ, Penido C, Henriques MG (2010) Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects. Br J Pharmacol 161:911–924
Chan MM, Moore AR (2010) Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol 184:6418–6426
Hashimoto A, Hayashi I, Murakami Y, Sato Y, Kitasato H, Matsushita R et al (2007) Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. J Rheumatol 34:2144–2153
Thomas E, Leroux JL, Blotman F, Chavis C (1995) Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis. Inflamm Res 44:121–124
Katoh T, Lakkis FG, Makita N, Badr KF (1994) Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. Kidney Int 46:341–349
Jiang C, Wang H, Xue M, Lin L, Wang J, Cai G et al (2019) Reprograming of peripheral Foxp3+ regulatory T cell towards Th17-like cell in patients with active systemic lupus erythematosus. Clin Immunol 108267. https://doi.org/10.1016/j.clim.2019.108267
Mohammadi S, Sedighi S, Memarian A (2019) IL-17 is aberrantly overexpressed among under-treatment Systemic Lupus Erythematosus patients. Iran J Pathol 14:236–242
Nordin F, Shaharir SS, Abdul Wahab A, Mustafar R, Abdul Gafor AH, Mohamed Said MS et al (2019) Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus. Int J Rheum Dis 22:1419–1426
Zhang Q, Liu S, Ge D, Cunningham DM, Huang F, Ma L et al (2017) Targeting Th17-IL-17 pathway in prevention of micro-invasive prostate cancer in a mouse model. Prostate 77:888–899
Zhang Q, Liu S, Parajuli KR, Zhang W, Zhang K, Mo Z et al (2017) Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene 36:687–699
Wang B, Zhao CH, Sun G, Zhang ZW, Qian BM, Zhu YF et al (2019) IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65. Cancer Lett 447:93–104
Zhang Y, Wang ZC, Zhang ZS, Chen F (2018) MicroRNA-155 regulates cervical cancer via inducing Th17/Treg imbalance. Eur Rev Med Pharmacol Sci 22:3719–3726
Changchun K, Pengchao H, Ke S, Ying W, Lei W (2017) Interleukin-17 augments tumor necrosis factor α-mediated increase of hypoxia-inducible factor-1α and inhibits vasodilator-stimulated phosphoprotein expression to reduce the adhesion of breast cancer cells. Oncol Lett 13:3253–3260
Akbay EA, Koyama S, Liu Y, Dries R, Bufe LE, Silkes M et al (2017) Interleukin-17A promotes lung tumor progression through neutrophil attraction to tumor sites and mediating resistance to PD-1 blockade. J Thorac Oncol 12:1268–1279
Borbiro I, Badheka D, Rohacs T (2015) Activation of TRPV1 channels inhibits mechanosensitive Piezo channel activity by depleting membrane phosphoinositides. Sci Signal 8:ra15. https://doi.org/10.1126/scisignal.2005667
Romero LO, Massey AE, Mata-Daboin AD, Sierra-Valdez FJ, Chauhan SC, Cordero-Morales JF et al (2019) Dietary fatty acids fine-tune Piezo1 mechanical response. Nat Commun 10(1):1200. https://doi.org/10.1038/s41467-019-09055-7
Accardi A (2015) Lipids link ion channels and cancer. Science 349:789–790
Liu CSC, Raychaudhuri D, Paul B, Chakrabarty Y, Ghosh AR, Rahaman O et al (2018) Piezo1 mechanosensors optimize human T cell activation. J Immunol 200:1255–1260
Chandy KG, Norton RS (2016) Channelling potassium to fight cancer. Nature 537:497–498
Ordway R, Walsh JV Jr, Singer JJ (1989) Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science 244:1176–1179
Kim D, Clapham DE (1989) Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science 244:1174–1176
Amoroso S, Schmid-Antomarchi H, Fosset M, Lazdunskit M (1990) Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels. Science 247:852–854
Isaacs JT (2013) Prostate cancer takes nerve. Science 341:134–135
Hayakawa Y, Wang TC (2017) Nerves switch on angiogenic metabolism. Science 358:305–306
Barria A (2019) Dangerous liaisons as tumours form synapses. Nature 573:1–2
Walev I, Klein J, Husmann M, Valeva A, Strauch S, Wirtz H et al (2000) Potassium regulates IL-1β processing via calcium-independent phospholipase A2. J Immunol 164:5120–5124
Walev I, Reske K, Palmer M, Valeva A, Bhakdi S (1995) Potassium-inhibited processing of IL-1β in human monocytes. EMBO J 14:1607–1614
Hughes FM Jr, Bortner CD, Purdy GD, Cidlowski JA (1997) Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 272:30567–30576
McGowan SE, Jackson SK, Doro MM, Olson PJ (1997) Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts. Am J Physiol 273:L1249–L1257
Das UN (1993) Oxy radicals and their clinical implications. Curr Sci 65:964–968
Lin HL, Liu TY, Chau GY, Lui WY, Chi CW (2000) Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer 89:983–994
Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407:390–395
Das UN (2002) A radical approach to cancer. Med Sci Monit 8:RA79–RA92
Ge Y, Byun JS, De Luca P, Gueron G, Yabe IM, Sadiq-Ali SG et al (2008) Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol. Mol Pharmacol 74:872–883
Colquhoun A (2009) Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction. J Urol 181:1885–1893
Naidu MR, Das UN, Kishan A (1992) Intratumoral gamma-linoleic acid therapy of human gliomas. Prostaglandins Leukot Essent Fatty Acids 45:181–184
Das UN, Prasad VV, Reddy DR (1995) Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 94:147–155
Bakshi A, Mukherjee D, Bakshi A, Banerji AK, Das UN (2003) Gamma-linolenic acid therapy of human gliomas. Nutrition 19:305–309
Das UN (2007) Gamma-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies. Med Sci Monit 13:RA119–RRA31
Reddy DR, Prasad VS, Das UN (1998) Intratumoural injection of gamma linolenic acid in malignant gliomas. J Clin Neurosci 5:36–39
Smith DL, Willis AL, Mahmud I (1984) Eicosanoid effects on cell proliferation in vitro: relevance to atherosclerosis. Prostaglandins Leukot Med 16:1–10
Sakai T, Yamaguchi N, Shiroko Y, Sekiguchi M, Fujii G, Nishino H (1984) Prostaglandin D2 inhibits the proliferation of human malignant tumor cells. Prostaglandins 27:17–26
Rohrbach S (2009) Effects of dietary polyunsaturated fatty acids on mitochondria. Curr Pharm Des 15:4103–4116
Tuo Y, Wang D, Li S, Chen C (2011) Long-term exposure of INS-1 rat insulinoma cells to linoleic acid and glucose in vitro affects cell viability and function through mitochondrial-mediated pathways. Endocrine 39:128–138
Zeghichi-Hamri S, de Lorgeril M, Salen P, Chibane M, de Leiris J, Boucher F et al (2010) Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats. Nutr Res 30:849–857
Hagopian K, Weber KL, Hwee DT, Van Eenennaam AL, López-Lluch G, Villalba JM et al (2010) Complex I-associated hydrogen peroxide production is decreased and electron transport chain enzyme activities are altered in n-3 enriched fat-1 mice. PLoS One 5:e12696. https://doi.org/10.1371/journal.pone.0012696
Kansal S, Negi AK, Kaur R, Sarotra P, Sharma G, Aggarwal R et al (2011) Evaluation of the role of oxidative stress in chemopreventive action of fish oil and celecoxib in the initiation phase of 7,12-dimethyl benz(α)anthracene-induced mammary carcinogenesis. Tumour Biol 32:167–177
Virgili F, Santini MP, Canali R, Polakowska RR, Haake A, Perozzi G (1998) Bcl-2 overexpression in the HaCaT cell line is associated with a different membrane fatty acid composition and sensitivity to oxidative stress. Free Radic Biol Med 24:93–101
Sailaja P, Dwarakanath BS, Das UN (2018) Arachidonic acid activates extrinsic apoptotic pathway to enhance tumoricidal action of bleomycin against IMR-32 cells. Prostaglandins Leukot Essen Fatty Acids 132:16–22
Dymkowska D, Wojtczak L (2009) Arachidonic acid-induced apoptosis in rat hepatoma AS-30D cells is mediated by reactive oxygen species. Acta Biochim Pol 56:711–715
Ribeiro G, Benadiba M, de Oliveira SD, Colquhoun A (2010) The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro. Cell Biochem Funct 28:15–23
Giros A, Grzybowski M, Sohn VR, Pons E, Fernandez-Morales J, **cola RM et al (2009) Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev Res (Phila) 2:732–742
Das UN (2011) Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Clin Lipidol 6:463–489
Halliwell BA (2000) Superway to kill cancer cells? Nature Med 6:1105–1106
Ponnala S, Rao KP, Chaudhury JR, Ahmed J, Rama Rao B, Kanjilal S et al (2009) Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot Essent Fatty Acids 80:43–50
Das UN, Rao KP (2006) Effect of gamma-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot Essent Fatty Acids 74:165–173
Das UN, Ramadevi G, Rao KP, Rao MS (1985) Prostaglandins and their precursors can modify genetic damage-induced by gamma-radiation and benzo(a)pyrene. Prostaglandins 29:911–920
Das UN (2006) Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives. Curr Pharm Biotechnol 7:457–466
Dhayal S, Morgan NG (2011) Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cells. Br J Pharmacol 162:1340–1350
Suresh Y, Das UN (2003) Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of omega-6 fatty acids. Nutrition 19:93–114
Suresh Y, Das UN (2003) Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. Nutrition 19:213–228
Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136–141
Sangeetha PS, Das UN (1993) Gamma-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med Sci Res 21:457–459
Madhavi N, Das UN (1994) Reversal of KB-3-1 and KB-Ch-8-5 tumor cell drug-resistance by cis-unsaturated fatty acids in vitro. Med Sci Res 22:689–692
Madhavi N, Das UN (1994) Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Cancer Lett 84:31–41
Das UN, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P (1998) Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Essent Fatty Acids 58:39–54
Germain E, Chajès V, Cognault S, Lhuillery C, Bougnoux P (1998) Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer 75:578–583
Mahéo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P et al (2005) Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med 39:742–751
Ilc K, Ferrero JM, Fischel JL, Formento P, Bryce R, Etienne MC et al (1999) Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines. Anticancer Drugs 10:413–417
Menendez JA, Ropero S, Lupu R, Colomer R (2004) Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression. Oncol Rep 11:1241–1252
Menéndez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E et al (2002) Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells. Breast Cancer Res Treat 72:203–219
Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R (2004) Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int J Oncol 24:1369–1383
Kong X, Ge H, Chen L, Liu Z, Yin Z, Li P et al (2009) Gamma-linolenic acid modulates the response of multidrug-resistant K562 leukemic cells to anticancer drugs. Toxicol In Vitro 23:634–639
Buckingham LE, Balasubramanian M, Safa AR, Shah H, Komarov P, Emanuele RM et al (1998) Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int J Cancer 65:74–79
Ramesh G, Das UN, Koratkar R, Padma M, Sagar PS (1992) Effect of essential fatty acids on tumor cells. Nutrition 8:343–347
Huang ZH, Hii CS, Rathjen DA, Poulos A, Murray AW, Ferrante A (1997) N-6 and N-3 polyunsaturated fatty acids stimulate translocation of protein kinase C alpha, beta I, beta II and –epsilon and enhance agonist-induced NADPH oxidase in macrophages. Biochem J 325:553–557
Peterson DA, Mehta N, Butterfield J, Husak M, Christopher MM, Jagarlapudi S et al (1988) Polyunsaturated fatty acids stimulate superoxide formation in tumor cells: a mechanism for specific cytotoxicity and a model for tumor necrosis factor? Biochem Biophys Res Commun 155:1033–1037
Chiu LC, Wan JM (1999) Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett 145:17–27
Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP et al (2000) Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res 60:4139–4145
Chen ZY, Istfan NW (2001) Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot Essen Fatty Acids 64:67–73
Anasuya HD, Naidu VGM, Das UN (2018) n-6 and n-3 Fatty acids and their metabolites augment inhibitory action of doxorubicin on the proliferation of human neuroblastoma (IMR-32) cells by enhancing lipid peroxidation and suppressing Ras, Myc, and Fos. Biofactors 44:387–401
Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahsafaei A, Harneit S et al (2006) Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 60:2919–2925
Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H (2000) Gαi and Gαo are target proteins of reactive oxygen species. Nature 408:492–495
Bai Y, Wang J, He Z, Yang M, Li L, Jiang H (2019) Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor β (TGF-β)/smad pathway and pro-inflammatory cytokines. Med Sci Monit 25:3069–3076
Wada K, Arita M, Nakajima A, Katayama K, Kudo C, Kamisaki Y et al (2006) FASEB J 2:1785–1792
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Das, U.N. (2020). Bioactive Lipids in Age-Related Disorders. In: Guest, P. (eds) Reviews on New Drug Targets in Age-Related Disorders. Advances in Experimental Medicine and Biology(), vol 1260. Springer, Cham. https://doi.org/10.1007/978-3-030-42667-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-42667-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42666-8
Online ISBN: 978-3-030-42667-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)